Valion Bio, Inc. (VBIO): Shareholders' Equity
$16.80M
As of 2025-12-31
$4.25M
As of 2026-06-30
+66.6%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $16.80M | +562.6% | 2026-03-30, Balance as of period end |
| 2024-12-31 | $2.54M | -29.2% | 2026-03-30, Balance as of period end |
| 2023-12-31 | $3.58M | -1.4% | 2025-03-21, Balance as of period end |
| 2022-12-31 | $3.63M | -72.6% | 2024-03-25, Balance as of period end |
| 2021-12-31 | $13.27M | n/a | 2023-03-31, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Valion Bio, Inc. (VBIO) | 2025-12-31 | $16.80M | +562.6% |
| Nuvectis Pharma, Inc. (NVCT) | 2025-12-31 | $18.41M | +89.6% |
| Equillium, Inc. (EQ) | 2025-12-31 | $28.60M | +50.0% |
| Tvardi Therapeutics, Inc. (TVRD) | 2025-12-31 | $20.95M | n/m |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $22.74M | +193.5% |
| Dare Bioscience, Inc. (DARE) | 2025-12-31 | $2.84M | n/m |
| PDS Biotechnology Corp (PDSB) | 2025-12-31 | $9.25M | n/a |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $27.77M | -46.7% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $23.04M | -2.0% |
Compare VBIO, NVCT, EQ, TVRD side by side · Screen every company in Pharmaceutical Preparations ↗